Very excited to see #TACTIC trial presented. A proof of concept that patient self selection for non prescription statin (rosuva 5) had >90% correct self selection, >98% correct use, & >35% LDL-C lowering. #ACC24 A potential mechanism to address primary prevention treatment gap!

Presented at #ACC24 :

Hospitalized patients with acute myocardial infarction & preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: nej.md/4akVhRx

#LargeLanguageModels can outperform medical experts in clinical text summarization, according to research led by AIMI Associate Director Akshay Chaudhari & published by Nature Medicine. go.nature.com/3xkdqQG

Took my first look at Suno. I created this in < 2 min from first visiting the site (lyrics from ChatGPT). Zero editing.

Imagine what can be done w time by someone who knows what they're doing.

Anyone who thinks tech like this won't devastate the music industry is in denial.

Don't miss out on today's session on multimodality imaging of CAD, where Mouaz Al-Mallah, M.D MSc is presenting on CMR vs PET for myocardial ischemia detection.

If you are in Atlanta for #ACC24 , join these bright young presenters from Houston Methodist Houston Methodist CV cardiac PET and CTA labs for outstanding moderated and flat board posters

Fares Ahdab, MD, MSc Malek Nayfeh Ahmed Ibrahim Ahmed, MD MPH Jean Michel Saad Mahmoud Al Rifai

WilliamZoghbi

Out in JACC Journals

Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States

Highlighting #ACC24 trials I'm excited about in the THREE DAYS before the conference!

First up: REDUCE-AMI

After 2023 Chronic coronary disease guidelines w/ 2b recommendation for reassessment of long-term B-blocker post-MI w/ EF >50%, more data here will be huge

JACC Journals

Preclerkship Medical Students’ Use of Third-Party Learning Resources. jamanetwork.com/journals/jaman…

'Odds ratios overestimate the relative risk'. I cannot read this without thinking 'concerningly, sausages do not taste like broccoli'.

Surprised to see losartan topping this list.

When starting an ARB, losartan is the last option I'd go with, for one simple reason.

🧵 /1

My thoughts on our recent JAMA paper on industry influence and Sowell's Conflict of Visions

johnmandrola.substack.com/p/our-jama-pap…

Thanks Andrew Foy Joseph Ross Ahmed Sayed and Dr. Lisa Soleymani Lehmann

Congratulations to Mouaz Al-Mallah, M.D MSc for his recent appointment as associate editor for #EHJ . I know you will make valuable contributions to the Journal. Houston Methodist CV WilliamZoghbi @

Validation of a fully automated deep learning-enabled solution for CCTA atherosclerotic plaque and stenosis quantification in a diverse real-world cohort Journal of Cardiovascular CT Heart_SCCT

authors.elsevier.com/a/1iqmw6tu1iBP…

Daniel Lorenzatti, MD. Annalisa Filtz Pamela Piña S. Andrea Scotti Aldo L Schenone, MD…

At CarDS Lab, we are recruiting a clinical research coordinator for our multicenter studies focusing on prospective evaluation of AI & digital health technologies

An opportunity to work with a dynamic, diverse & driven team working to transform care
🔗cards-lab.org/clinical-resea…

Study examines the distribution of payments within and across specialties and the medical products associated with the largest total payments.

ja.ma/43C3Wwe